Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maureen E. Canavan, PhD"'
Autor:
Attila Nemeth, MD, Maureen E. Canavan, PhD, MPH, Peter L. Zhan, MD, Brooks V. Udelsman, MD, MHS, Sora Ely, MD, Dennis A. Wigle, MD, PhD, Linda Martin, MD, MPH, Chi-Fu Jeffrey Yang, MD, Daniel J. Boffa, MD, MBA, Andrew P. Dhanasopon, MD
Publikováno v:
JTCVS Open, Vol 20, Iss , Pp 141-150 (2024)
Objectives: Patients with non–small cell lung cancer treated with immunotherapy and modern chemoradiation regimens show improved progression-free and overall survival. However, patients with limited oligo-progression represent a potential populatio
Externí odkaz:
https://doaj.org/article/ff2bc81d615a4e4f9e53b06009f481d0
Autor:
Peter Lee Zhan, MD, Maureen E. Canavan, PhD, MPH, Theresa Ermer, MD, Matthew D. Pichert, MD, MPH, Andrew X. Li, MD, Richard C. Maduka, MD, Michael F. Kaminski, BA, Kimberly L. Johung, MD, PhD, Daniel J. Boffa, MD, MBA
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100429- (2022)
Introduction: For patients with stage IV esophageal cancer, esophageal radiation may be used selectively for local control and palliation. We aimed to understand patterns of radiation administration among patients with stage IV esophageal cancer and
Externí odkaz:
https://doaj.org/article/21b28d4cdb7d44f1be3a2d00a83ce1cb
Autor:
Peter L. Zhan, MD, Maureen E. Canavan, PhD, MPH, Theresa Ermer, MD, Matthew D. Pichert, MD, MPH, Andrew X. Li, MD, Richard C. Maduka, MD, Michael F. Kaminski, BA, Daniel J. Boffa, MD, MBA
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100426- (2022)
Introduction: Metastatic involvement of at least one nonregional lymph node currently renders patients with esophageal cancer as having stage IV disease. However, the management and outcomes of patients whose sole determinant of stage IV status is no
Externí odkaz:
https://doaj.org/article/cc57832c9b094ed181561b10ef4371f6
Autor:
Matthew D. Pichert, MD, Maureen E. Canavan, PhD, MPH, Richard C. Maduka, MD, Andrew X. Li, MD, Theresa Ermer, MD, Peter L. Zhan, MD, Michael Kaminski, BA, Brooks V. Udelsman, MD, MHS, Justin D. Blasberg, MD, MPH, Vincent J. Mase, Jr., MD, Andrew P. Dhanasopon, MD, Daniel J. Boffa, MD, MBA
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100318- (2022)
Introduction: Available guidelines are inconsistent as to whether patients with newly diagnosed clinical stage II NSCLC should receive routine brain imaging. Methods: The National Cancer Database was queried for the prevalence of isolated brain metas
Externí odkaz:
https://doaj.org/article/36339c243c854a4db6014f5460b22d58
Autor:
Michelle C. Salazar, MD, Maureen E. Canavan, PhD, Samantha L. Walters, BS, Sitaram Chilakamarry, MD, Theresa Ermer, MD, Justin D. Blasberg, MD, James B. Yu, MD, MHS, Cary P. Gross, MD, Daniel J. Boffa, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100143- (2021)
Introduction: Patients with early-stage NSCLC typically must choose between a surgery with superior local control (lobectomy) or one that preserves lung parenchyma (wedge). Recognizing that many patients with cancer have competing mortality risks unr
Externí odkaz:
https://doaj.org/article/bba755ee2fef4543b78b298aded765c4